Robert G. Savage
Robert G. Savage has been a member of our Board since December 2004, and serves as Chairman. Mr. Savage has been a top pharmaceutical executive for almost 20 years. He held the position of Worldwide Chairman of the Pharmaceuticals Group at Johnson & Johnson with annual net sales of over $13 billion and was both a Company Officer and a member of the Executive Committee. He also served Johnson & Johnson in the capacity of a Company Group Chairman and President of Ortho-McNeil Pharmaceuticals. Most recently, Mr. Savage was President for the General Therapeutics and Inflammation Business for Pharmacia Corporation where he was President of the Worldwide Inflammation Group. He has held multiple positions leading marketing, business development and strategic planning at Hoffmann-La Roche and Sterling Drug. Mr. Savage is a director of The Medicines Company, a specialty pharmaceutical company as well as Noven Pharmaceuticals and NovaDel Pharma Inc., both drug delivery companies. Mr. Savage received a B.S. in Biology from Upsala College and an M.B.A. from Rutgers University.